Donate
Back to Clinical Trials
Back to Clinical Trials

Brief Title: Familial and Atypical Urothelial Cancer Registry

A Genotype-Phenotype Urothelial Cancer Registry

INTRODUCTION

  • Org Study ID: 09-025
  • Secondary ID: N/A
  • NCT ID: NCT00902590
  • Sponsor: Memorial Sloan Kettering Cancer Center

BRIEF SUMMARY

This study is being done to create a registry to help us learn more about urinary and other cancers. This will let us look at large groups of people who do and do not have this kind of cancer.

The investigators will look at risk factors to learn more about how these impact cancer. The investigators will also look at genetic markers. These are genes that are found in a known place. They are often associated with a particular trait. If the gene changes in some way, it may predict cancer or response to treatment. The investigators will look for markers in your saliva.

This registry will help us develop better methods of:

Preventing these cancers. Diagnosing these cancers. Treating these cancers.

  • Overall Status
    Recruiting
  • Start Date
    May, 2009
  • Phase
  • Study Type
    Observational

PRIMARY OUTCOMES

Primary Outcome 1 - Measure:

Primary Outcome 1 - Timeframe: N/A

CONDITION

  • Urothelial Cancer
  • Renal Pelvis Cancer
  • Ureter Cancer
  • Bladder Cancer

ELIGIBILITY

Inclusion Criteria:
Urothelial Cancer Cases
* Must be ≥ 18 years of age AND

- * Must have a diagnosis of urothelial cancer AND

- * Must be an English-speaker
Non-Cancer Control Group
* Must be ≥ 18 years of age AND

- * Must not have cancer or a personal history of cancer, with the exception of skin cancer. AND

- * Must not be a blood relative of cases AND

- * Must not be a blood relative of another control AND

- * Must be an English-speaker
Family Member Control Group:
In select kindreds with a high prevalence of bladder cancer and/or very early onset bladder cancer, first- and second-degree family members of probands may be contacted by the MSKCC study team and invited to complete the questionnaire and submit a saliva sample.
* Must be ≥ 18 years of age AND

- * Must be a blood relative of a case participant AND

- * Must be an English-speaker
Exclusion Criteria:
* Have any condition, which in the opinion of the primary MSKCC clinician or investigators precludes their ability to provide informed consent.

Gender: All

Minimum Age: 18 Years

Maximum Age: N/A

Healthy Volunteers: No

OFFICIAL INFORMATION

Name: Dean Bajorin, MD

Role: Principal Investigator

Affiliation: Memorial Sloan Kettering Cancer Center

Overall Contact

Name: Dean Bajorin, MD, Helena Furberg-Barnes, PhD

Phone: 646-422-4333, 646-735-8118

Email: N/A

LOCATION

Facility Status Contact

Read Our Stories